AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $966,000 | +13.4% | 90 | 0.0% | 0.00% | – |
Q1 2022 | $852,000 | -18.0% | 90 | 0.0% | 0.00% | – |
Q4 2021 | $1,039,000 | +21.0% | 90 | 0.0% | 0.00% | – |
Q3 2021 | $859,000 | +4.5% | 90 | 0.0% | 0.00% | – |
Q2 2021 | $822,000 | -7.5% | 90 | 0.0% | 0.00% | – |
Q1 2021 | $889,000 | -57.2% | 90 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $2,078,000 | +63.5% | 90 | 0.0% | 0.00% | – |
Q3 2020 | $1,271,000 | -6.3% | 90 | 0.0% | 0.00% | – |
Q2 2020 | $1,357,000 | -91.8% | 90 | -95.0% | 0.00% | -100.0% |
Q1 2020 | $16,548,000 | -81.9% | 1,791 | -79.6% | 0.01% | -70.6% |
Q4 2019 | $91,402,000 | +29.5% | 8,800 | 0.0% | 0.02% | +30.8% |
Q3 2019 | $70,562,000 | -35.7% | 8,800 | 0.0% | 0.01% | -31.6% |
Q2 2019 | $109,782,000 | -8.2% | 8,800 | 0.0% | 0.02% | -20.8% |
Q1 2019 | $119,633,000 | +42.0% | 8,800 | 0.0% | 0.02% | +60.0% |
Q4 2018 | $84,278,000 | -20.8% | 8,800 | 0.0% | 0.02% | -25.0% |
Q3 2018 | $106,352,000 | -22.6% | 8,800 | 0.0% | 0.02% | -13.0% |
Q2 2018 | $137,398,000 | – | 8,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |